Research background · Updated November 1, 2026
Vilon Research: Publications, Study Types and Background
Short answer
Vilon. As of November 1, 2026, PubMed indexes 50 records matching Vilon, the earliest from 1997; 3 were published in 2021–2025 and 2 are reviews. ClinicalTrials.gov lists 1 registered study matching the compound.
- PubMed records
- 50
- Earliest record
- 1997
- Published 2021–2025
- 3
- Reviews
- 2
- Animal-only studies
- 31
- Registered studies
- 1
Publications per year, 2006–2025
7 records in 2016–2025 against 11 in 2006–2015; the busiest year was 2013, with 3.
See the numbers
| Year | PubMed records |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 0 |
| 2010 | 0 |
| 2011 | 1 |
| 2012 | 0 |
| 2013 | 3 |
| 2014 | 2 |
| 2015 | 0 |
| 2016 | 0 |
| 2017 | 2 |
| 2018 | 0 |
| 2019 | 0 |
| 2020 | 2 |
| 2021 | 0 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 0 |
| 2025 | 0 |
Study types
| All PubMed records | 50 |
|---|---|
| Reviews | 24% |
| Animal studies (no human subjects indexed) | 3162% |
| Indexed as clinical trials | 12% |
| Registered on ClinicalTrials.gov | 1 |
Categories overlap and follow PubMed’s own indexing; recent records may not be indexed yet.
Primary research directions
What 2 of the most-cited and most recent Vilon papers report, in their own authors’ terms. Each line links the paper it came from.
Post-radiation recovery
In irradiated animals, vilon increased the proliferative activity of thymocytes and the proliferative potential of intestinal stem cells, which the authors describe as stimulating recovery of these organs.
AnimalsKhavinson VK 2001Bulletin of experimental biology and medicinePMID 11427924
Chromatin in ageing lymphocytes
In lymphocytes from older individuals, the bioregulator peptides Epitalon, Livagen and Vilon caused activation (deheterochromatinization) of chromatin, though vilon did not affect pericentromeric structural heterochromatin.
CellsLezhava T 2006Georgian medical newsPMID 16705247
Most-studied topics
The Medical Subject Headings (MeSH) PubMed indexers most often marked as a main topic, across 50 of the 50 records. They describe what the literature is about, not what Vilon does.
- Dipeptides30 papers
- Aging11 papers
- Adjuvants, Immunologic6 papers
- Thymus Gland5 papers
- Spleen5 papers
- Interleukin-25 papers
- Lymphocytes4 papers
- Hypothalamus4 papers
Key papers
Earliest indexed record
Morozov VG (1997). International journal of immunopharmacology.
PMID 9637345Most-cited paper · 44 citations
Morozov VG (1997). International journal of immunopharmacology.
PMID 9637345Most-cited #2 · 24 citations
Anisimov VN (2002). International journal of cancer.
PMID 12209581Most-cited #3 · 17 citations
Avolio F (2022). International journal of molecular sciences.
PMID 35408963
Citation counts from NIH iCite, among the 50 records sampled. Titles are left out; open each record on PubMed to read it.
Identity
| CAS | 45234-02-4 |
|---|---|
| Molecular formula | C11H21N3O5 |
| Molecular weight | 275.30 g/mol |
| Synonyms | lysylglutamic acid, Lys-Glu, Peptide vilon, Vilon, L-LYSYL-L-GLUTAMIC ACID |
Identity data from PubChem, retrieved November 1, 2026, on the Vilon page.
How these numbers were counted
- PubMed search, run November 1, 2026:
vilon[tiab] AND (peptide[tiab] OR Khavinson[au])re-run it. Study types add PubMed’s own filters (review, clinical trial, animals not humans). - Topics: MeSH major-topic headings counted across up to 400 of the matching records; headings for study set-up (species, sex, age) are left out.
- Citations: NIH iCite citation counts for the same records.
- ClinicalTrials.gov search:
vilonre-run it. Any phase, any status.
This page reports what has been published and what papers say they found, with each source linked. It gives no dosing or usage information, and nothing here is a reason to use Vilon outside a laboratory.
Wholesale supply
Vilon, sourced to order for research.
Not held in the listed catalog. Tell us the vial size and the number of vials and we come back with availability, documentation and pricing in writing.
Vilon research questions
How much research has been published on Vilon?
PubMed indexes 50 records matching Vilon (searched November 1, 2026), including 2 reviews and 1 records indexed as clinical trials. 3 were published in the five years 2021–2025.
When was Vilon first described in the literature?
The earliest PubMed record matching Vilon is from 1997 (Morozov VG, International journal of immunopharmacology, PMID 9637345).
What topics does the Vilon literature cover?
The subject headings PubMed indexers most often marked as a main topic of Vilon papers are Dipeptides, Aging, Adjuvants, Immunologic, Thymus Gland. These describe what the literature is about. Findings from individual papers, with their sources, are summarized on this page.
Is Vilon sold for human use?
No. Vanta Foundry supplies it for laboratory research use only. Not for human or veterinary use, and not a drug, food, cosmetic or dietary supplement.
Where can I buy Vilon wholesale for research?
We source Vilon to order rather than stock it. Tell us the vial size and number of vials on WhatsApp or by email and the quote confirms availability, documentation and pricing.
Research materials supplied by Vanta Foundry are for laboratory research use only. They are not for human or veterinary use and are not drugs, foods, cosmetics or dietary supplements. Websites and payment processing are business services for research-supply brands.
All compounds: research peptide publication statistics.